Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sony Corp And Olympus Corp Update On Status For Establishment Of Medical Business Venture Company


Tuesday, 2 Apr 2013 02:01am EDT 

Olympus Corp (Olympus) and Sony Corp (Sony) updated the status of the medical business venture company (the medical business venture) that has been the subject of discussions between the two parties, and which will be established in accordance with the business alliance agreement executed on September 28, 2012. Olympus and Sony announced in the press release 'Update on the Status for Establishment of Medical Business Venture Company between Olympus and Sony' dated December 21, 2012 that the companies aimed to establish the medical business venture by April 1, 2013, subject to customary closing conditions, including the receipt of any necessary regulatory approvals. The examination by the relevant authority is taking longer than expected, but the Company understand the examination process is currently in its final stage. Olympus and Sony expect to announced establishment of the medical business venture promptly after the establishment date is fixed. 

Company Quote

4185.0
35.0 +0.84%
9:19pm EST